Evaluation of the 29 MHz Micro-Ultrasound Imaging
for Prostate Cancer Diagnosis and Treatment

Whitney Stanton; E. David Crawford; Paul Arangua; Gretchen Hoyer; Priya N Werahera

Short Communication

Evaluation of the 29 MHz Micro-Ultrasound Imaging for Prostate Cancer Diagnosis and Treatment

Whitney Stanton¹*, E. David Crawford², Paul Arangua¹, Gretchen Hoyer¹ and Priya N Werahera¹

¹University of Colorado Anschutz Medical Campus, Aurora, CO, USA

²University of California San Diego, San Diego, CA, USA

Corresponding Author

Received Date: June 16, 2019; Published Date: June 27, 2019

Abstract

We describe our experience with four patients undergoing cryotherapy for treatment of prostate cancer. Micro-ultrasound was utilized in conjunction with standard transrectal ultrasound to intraoperatively assess lesions. In addition, the results were compared to preoperative mpMRI in several patients. The use of micro-ultrasound has been evaluated in clinical trials to include real-time imaging in the clinic for biopsies and fusion with prior mpMRI. We evaluated the technique in men with known prostate cancer undergoing cryoablation. Micro-ultrasound has the potential to replace the current clinical methods for targeted prostate biopsies and improve intraoperative monitoring.

Keywords: Exact Imaging; mpMRI; Conventional ultrasound; Micro-ultrasound; Biopsy; Prostate cancer

Abbreviations: mpMRI: Multiparametric Magnetic Resonance Imaging; PSA: Prostate Specificantigen; PIRADS v2: Prostate Imaging and Reporting Data System Version 2; TRUS: Trans-Rectal Ultrasound

Article Details

Citation

Whitney Stanton, E. David Crawford, Paul Arangua, Gretchen Hoyer, et al. Evaluation of the 29 MHz Micro-Ultrasound Imaging for Prostate Cancer Diagnosis and Treatment. Annal Urol & Nephrol. 1(3): 2019. AUN.MS.ID.000515.